Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine
This article is from
The Cancer Letter
archive.
Vol. 35 No. 8 | August 31, 2012
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Pathology In Operating Suite Cuts Need for More Surgery
February 24, 2012
TCL Archive
Relative Survival Now May be Over 50%, DeVita Says
December 3, 1982
TCL Archive
Questions Raised By Committee Kills Still Not Resolved
July 29, 1977
TCL Archive
NCI Role, Issues In Education Considered By DRCCA Board
August 21, 1981
TCL Archive
ASCO Annual Meeting Abstracts Posted Online
May 28, 2010
TCL Archive
Plan To Reprogram $10 Million On Construction Funds Draws Criticism
November 19, 1976